Browsing by Subject "Antiretroviral therapy"
Now showing items 1-20 of 124
-
Access to anti-hypertensive and anti-diabetic medications amongst people living with HIV in Soroti District, Eastern Uganda
(Makerere University, 2022-12)Background: Access to anti-diabetic and anti-hypertensive medicines is one of the factors that needs to be addressed so as to ensure continuous availability of affordable quality of care to HIV clients living with ... -
An adherence monitoring system in antiretroviral therapy
(2007-05)This study investigated the use of a Multi-dimensional system to improve adherence monitoring in antiretroviral therapy (ART). The high adherence levels required during patient therapy and the consequences of adherence ... -
Adherence to antiretroviral therapy before and after substitution to Dolutegravir and associated factors among pregnant and postpartum mothers at the MUJHU supported facilities in Kampala - Uganda.
(Makerere University, 2023-01-19)Introduction: In 2020, the Uganda Ministry of health rolled out the use of dolutegravir based ART regimens as the preferred first line ART for all people living with HIV including the pregnant and postpartum mothers. Despite ... -
Adherence to antiretroviral therapy in HIV-positive adolescents in Uganda assessed by multiple methods a prospective cohort study
(Adis, 2012-10)Background: The effectiveness of traditional adherence measurements used in adolescent populations isdifficult to assess. Antiretroviral (ARV) adherence research among adolescents living with HIV in resourceconstrained ... -
Antiretroviral therapy improves cognitive impairment in HIV individuals in Sub-Saharan Africa
(American Academy of Neurology (AAN), 2006)Abstract—Background: Highly active antiretroviral therapy (HAART) can improve cognitive performance in some patients with HIV-associated cognitive impairment in the United States. The effect of HAART on HIV dementia ... -
Assessing quality of HIV Counselling services offered in public health facilities in Kampala
(Makerere University, 2016)Introduction: HIV counselling has increasingly become available in public health facilities in Uganda. Counselling is a key component in HIV/AIDS prevention programs as an entry point into care, treatment and support ... -
Assessment of the drug storage facilities and quality of generic co-formulation tablets (Stavudine, Lamivudine, Nevirapine) at HIV/AIDS treatment centers in Uganda.
(Medwell Journals, 2008)The study investigated the storage facilities and the quality of co-formulation tablets containing stavudine, lamivudine, and nevirapine at four treatment centres in Uganda. A cross-sectional survey of drug storage conditions ... -
Barriers to timely antiretroviral therapy initiation among HIV infected children attending TASO clinics at Tororo, Mulago and Jinja
(Makerere University, 2014-02-20)Background: statistics show an increase in the prevalence and incidence of HIV among children yet these figures do not match with the numbers on treatment. Records showed evidence of delayed ART initiation (initiation ... -
Belief in divine healing can be a barrier to antiretroviral therapy adherence in Uganda
(Lippincott Williams & Wilkins., 2007)Although recent data suggest high levels of adherence to expanding antiretroviral therapy (ART) programmes in resource-limited settings, the culture- specific barriers to adherence are poorly understood. In a prospective ... -
Bilateral pedal edema in an HIV patient: Lopinavir/Ritonavir-containing treatment regimen as a potential cause?
(Open Learning on Enteric Pathogens, 2009-03)A large number of patients are switched to second-line antiretroviral therapy, especially in resource limited settings. Lopinavir/Ritonavir is the main drug used in second-line treatment regimens. We describe a patient ... -
Blood cell picture in HIV patients in Uganda: a comparative study of the picture in HIV patients on highly active antiretroviral therapy with those who are not
(Makerere University, 2004-01)Atleast 40 million people were infected with HIV World wide by the end of 2001, 90% of whom live in the developing countries. Less than 5% of these were able to access drugs that suppress the HIV Virus (ARVs) by the end ... -
Can response of a pruritic papular eruption to antiretroviral therapy be used as a clinical parameter to monitor virological outcome?
(Lippincott Williams & Wilkins, 2008)Background: A pruritic papular eruption (PPE) is a common skin manifestation observed in 12–46% of persons with HIV infection living in tropical countries. Objective: To determine whether PPE responds to HAART and whether ... -
Cardiac dysfunction among HIV infected children on combination antiretroviral therapy attending joint clinical research centre, Kampala, Uganda.
(Makerere University, 2013)Introduction Human Immunodeficiency virus still remains a global problem. Cardiac dysfunction is highly prevalent among symptomatic ART naïve HIV infected children with advanced disease. Earlier studies have described ... -
A case report: Harpes zooster IRIS in pregnancy
(African Health Sciences, 2009)Pregnant women are increasingly being initiated on antiretroviral therapy either as part of prevention of mother to child transmission of HIV or as purely highly active antiretroviral therapy. In this case report, we ... -
Cause-Specific Mortality and the Contribution of Immune Reconstitution Inflammatory Syndrome in the First 3 Years after Antiretroviral Therapy Initiation in an Urban African Cohort
(Infectious Diseases Society of America, 2009)Background. Although many studies have reported high early mortality among patients enrolled in antiretroviral therapy (ART) programs in sub-Saharan Africa—particularly among those individuals with advanced immunodeficiency— ... -
Challenges faced by health workers in providing counselling services to HIV-positive children in Uganda: a descriptive study
(BioMed Central, 2010)Background: The delivery of HIV counselling and testing services for children remains an uphill task for many health workers in HIV-endemic countries, including Uganda. We conducted a descriptive study to explore the ... -
Characteristics of HIV-1 discordant couples enrolled in a trial of HSV-2 suppression to reduce HIV-1 transmission: the partners study.
(Public Library of Science, 2009-04-30)Background: The Partners HSV-2/HIV-1 Transmission Study (Partners Study) is a phase III, placebo-controlled trial of daily acyclovir for genital herpes (HSV-2) suppression among HIV-1/HSV-2 co-infected persons to reduce ... -
Client and provider perspectives of the efficiency and quality of care in the context of rapid scale-up of antiretroviral therapy
(Mary Ann Liebert, 2010)Global scale-up of antiretroviral therapy (ART) has focused on clinical outcomes with little attention on its impact on existing health systems. In June–August 2008, we conducted a formative evaluation on ART scale-up and ... -
Clinical, immunological, virological characteristics, and hospitalisation outcomes of patients admitted to Kiruddu Hospital with advanced HIV disease
(Makerere University, 2022-08)Introduction Nearly four decades after the first case of AIDS was described, the global number of AIDS related deaths is not declining as expected to meet elimination targets, especially in sub-Saharan Africa where the ...